Sarah Bos

109 Efficacy of pro- and anticoagulant strategies in plasma 6 17 LebretonA, SinegreT, PereiraB, LamblinG, DuronC, Abergel A. Plasmahypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis. J Gastroenterol Hepatol; 2017; 32: 916–24. 18 Massicotte L, Thibeault L, Roy A. Classical Notions of Coagulation Revisited in Relation with Blood Losses, Transfusion Rate for 700 Consecutive Liver Transplantations. Semin Thromb Hemost 2015; 41: 538–46. 19 Potze W, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Hypercoagulability following major partial liver resection - Detected by thrombomodulin-modified thrombin generation testing. Aliment Pharmacol Ther 2015; 41: 189–98. 20 Mallett S V., Sugavanam A, Krzanicki DA, Patel S, Broomhead RH, Davidson BR, Riddell A, Gatt A, Chowdary P. Alterations in coagulation following major liver resection. Anaesthesia; 2016; 71: 657–68. 21 De Pietri L, Montalti R, Begliomini B, Scaglioni G, Marconi G, Reggiani A, Di Benedetto F, Aiello S, Pasetto A, Rompianesi G, Gerunda GE. Thromboelastographic changes in liver and pancreatic cancer surgery: Hypercoagulability, hypocoagulability or normocoagulability? Eur J Anaesthesiol 2010; 27: 608–16. 22 Biancofiore G, Blasi A, De Boer MT, Franchini M, Hartmann M, Lisman T, Liumbruno GM, Porte RJ, Saner F, Senzolo M, Werner MJ. Perioperative hemostatic management in the cirrhotic patient: A position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE). Minerva Anestesiologica. 2019;85:782-798. 23 Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DBL, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139–52. 24 Huber J, Stanworth SJ, Doree C, Fortin PM, Trivella M, Brunskill SJ, Hopewell S, Wilkinson KL, Estcourt LJ. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures. Cochrane Database of Systematic Reviews. 2019;11:CD012745 25 Rassi AB, D’Amico EA, Tripodi A, da Rocha TRF, Migita BY, Ferreira CM, Carrilho FJ, Farias AQ. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: Effect on conventional coagulation tests and thrombomodulin-modified thrombin generation. J Hepatol 2020;72:85-94 26 Bernal W, Caldwell SH, Lisman T. Nails in the coffin of fresh frozen plasma to prevent or treat bleeding in cirrhosis? Journal of Hepatology. 2020;72:12-13. 27 Hartmann M, Walde C, Dirkmann D, Saner FH. Safety of coagulation factor concentrates guided by ROTEMTM-analyses in liver transplantation: Results from 372 procedures. BMC Anesthesiol; 2019; 19: 97. 28 Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Porte RJ, Lisman T. Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis. Br J Haematol 2013; 163: 666–73. 29 Hoolwerf EW, Kraaijpoel N, Büller HR, van Es N. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review. Thrombosis Research 2018; 170:102–8. 30 Potze W, Arshad F, Adelmeijer J, Blokzijl H, Van Den Berg AP, Meijers JCM, Porte RJ, Lisman T. Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis. PLoS One 2014; 9: e88390.